1. Market Research
  2. > Healthcare Market Trends
  3. > Cataract Surgery Devices - Medical Devices Pipeline Assessment, 2015

Cataract Surgery Devices - Medical Devices Pipeline Assessment, 2015

Summary

GlobalData's Medical Devices sector report, “Cataract Surgery Devices - Medical Devices Pipeline Assessment, 2015" provides an overview of Cataract Surgery Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Cataract Surgery Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Cataract Surgery Devices under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Cataract Surgery Devices and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Cataract Surgery Devices under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table Of Contents

Cataract Surgery Devices - Medical Devices Pipeline Assessment, 2015
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 19
2 Introduction 20
2.1 Cataract Surgery Devices Overview 20
3 Products under Development 21
3.1 Cataract Surgery Devices - Pipeline Products by Stage of Development 21
3.2 Cataract Surgery Devices - Pipeline Products by Segment 22
3.3 Cataract Surgery Devices - Pipeline Products by Territory 23
3.4 Cataract Surgery Devices - Pipeline Products by Regulatory Path 24
3.5 Cataract Surgery Devices - Pipeline Products by Estimated Approval Date 25
3.6 Cataract Surgery Devices - Ongoing Clinical Trials 26
4 Cataract Surgery Devices - Pipeline Products under Development by Companies 27
4.1 Cataract Surgery Devices Companies - Pipeline Products by Stage of Development 27
4.2 Cataract Surgery Devices - Pipeline Products by Stage of Development 29
5 Cataract Surgery Devices Companies and Product Overview 37
5.1 Abbott Medical Optics, Inc. Company Overview 37
5.1.1 Abbott Medical Optics, Inc. Pipeline Products and Ongoing Clinical Trials Overview 37
5.2 Adoptics AG Company Overview 45
5.2.1 Adoptics AG Pipeline Products and Ongoing Clinical Trials Overview 45
5.3 Advanced Refractive Technologies, Inc. Company Overview 46
5.3.1 Advanced Refractive Technologies, Inc. Pipeline Products and Ongoing Clinical Trials Overview 46
5.4 AkkoLens International BV Company Overview 49
5.4.1 AkkoLens International BV Pipeline Products and Ongoing Clinical Trials Overview 49
5.5 Alcon, Inc. Company Overview 50
5.5.1 Alcon, Inc. Pipeline Products and Ongoing Clinical Trials Overview 50
5.6 Altacor Limited Company Overview 65
5.6.1 Altacor Limited Pipeline Products and Ongoing Clinical Trials Overview 65
5.7 Anew Optics, Inc. Company Overview 66
5.7.1 Anew Optics, Inc. Pipeline Products and Ongoing Clinical Trials Overview 66
5.8 Bausch and Lomb Incorporated Company Overview 67
5.8.1 Bausch and Lomb Incorporated Pipeline Products and Ongoing Clinical Trials Overview 67
5.9 Calhoun Vision, Inc. Company Overview 70
5.9.1 Calhoun Vision, Inc. Pipeline Products and Ongoing Clinical Trials Overview 70
5.10 Elenza, Inc. Company Overview 72
5.10.1 Elenza, Inc. Pipeline Products and Ongoing Clinical Trials Overview 72
5.11 Eye Care and Cure Company Overview 73
5.11.1 Eye Care and Cure Pipeline Products and Ongoing Clinical Trials Overview 73
5.12 EyeKon Medical, Inc. Company Overview 74
5.12.1 EyeKon Medical, Inc. Pipeline Products and Ongoing Clinical Trials Overview 74
5.13 Glaukos Corporation Company Overview 230
5.13.1 Glaukos Corporation Pipeline Products and Ongoing Clinical Trials Overview 230
5.14 Hoya Surgical Optics, Inc. Company Overview 234
5.14.1 Hoya Surgical Optics, Inc. Pipeline Products and Ongoing Clinical Trials Overview 234
5.15 HumanOptics AG Company Overview 235
5.15.1 HumanOptics AG Pipeline Products and Ongoing Clinical Trials Overview 235
5.16 Imperial Medical Technologies, Inc Company Overview 239
5.16.1 Imperial Medical Technologies, Inc Pipeline Products and Ongoing Clinical Trials Overview 239
5.17 InnFocus LLC Company Overview 242
5.17.1 InnFocus LLC Pipeline Products and Ongoing Clinical Trials Overview 242
5.18 Innovia LLC Company Overview 243
5.18.1 Innovia LLC Pipeline Products and Ongoing Clinical Trials Overview 243
5.19 International Biomedical Company Overview 244
5.19.1 International Biomedical Pipeline Products and Ongoing Clinical Trials Overview 244
5.20 LensGen, Inc. Company Overview 246
5.20.1 LensGen, Inc. Pipeline Products and Ongoing Clinical Trials Overview 246
5.21 London Eye Hospital Pharma Company Overview 247
5.21.1 London Eye Hospital Pharma Pipeline Products and Ongoing Clinical Trials Overview 247
5.22 Massachusetts Institute of Technology Company Overview 248
5.22.1 Massachusetts Institute of Technology Pipeline Products and Ongoing Clinical Trials Overview 248
5.23 Meir Medical Center Company Overview 249
5.23.1 Meir Medical Center Pipeline Products and Ongoing Clinical Trials Overview 249
5.24 Morcher Gmbh Company Overview 250
5.24.1 Morcher Gmbh Pipeline Products and Ongoing Clinical Trials Overview 250
5.25 Mynosys Cellular Devices, Inc. Company Overview 285
5.25.1 Mynosys Cellular Devices, Inc. Pipeline Products and Ongoing Clinical Trials Overview 285
5.26 NuLens Ltd. Company Overview 286
5.26.1 NuLens Ltd. Pipeline Products and Ongoing Clinical Trials Overview 286
5.27 Oculentis GmbH Company Overview 288
5.27.1 Oculentis GmbH Pipeline Products and Ongoing Clinical Trials Overview 288
5.28 OptMed, Inc. Company Overview 290
5.28.1 OptMed, Inc. Pipeline Products and Ongoing Clinical Trials Overview 290
5.29 OptoLight Vision Technology Company Overview 291
5.29.1 OptoLight Vision Technology Pipeline Products and Ongoing Clinical Trials Overview 291
5.30 Paradigm Medical Industries, Inc. Company Overview 292
5.30.1 Paradigm Medical Industries, Inc. Pipeline Products and Ongoing Clinical Trials Overview 292
5.31 PowerVision, Inc. Company Overview 293
5.31.1 PowerVision, Inc. Pipeline Products and Ongoing Clinical Trials Overview 293
5.32 Presbeasy Company Overview 297
5.32.1 Presbeasy Pipeline Products and Ongoing Clinical Trials Overview 297
5.33 Rayner Intraocular Lenses Limited Company Overview 298
5.33.1 Rayner Intraocular Lenses Limited Pipeline Products and Ongoing Clinical Trials Overview 298
5.34 Rhexis Biomedical Company Overview 317
5.34.1 Rhexis Biomedical Pipeline Products and Ongoing Clinical Trials Overview 317
5.35 Sharklet Technologies, Inc. Company Overview 318
5.35.1 Sharklet Technologies, Inc. Pipeline Products and Ongoing Clinical Trials Overview 318
5.36 STAAR Surgical Company Company Overview 319
5.36.1 STAAR Surgical Company Pipeline Products and Ongoing Clinical Trials Overview 319
5.37 Tear Diagno LLC Company Overview 324
5.37.1 Tear Diagno LLC Pipeline Products and Ongoing Clinical Trials Overview 324
5.38 TEKIA, Inc. Company Overview 325
5.38.1 TEKIA, Inc. Pipeline Products and Ongoing Clinical Trials Overview 325
5.39 University of Florida Company Overview 326
5.39.1 University of Florida Pipeline Products and Ongoing Clinical Trials Overview 326
5.40 University of Rochester Company Overview 327
5.40.1 University of Rochester Pipeline Products and Ongoing Clinical Trials Overview 327
5.41 University of Texas Medical Branch at Galveston Company Overview 328
5.41.1 University of Texas Medical Branch at Galveston Pipeline Products and Ongoing Clinical Trials Overview 328
5.42 Visioneering Technologies, Inc. Company Overview 329
5.42.1 Visioneering Technologies, Inc. Pipeline Products and Ongoing Clinical Trials Overview 329
5.43 Wake Forest Baptist Medical Center Company Overview 330
5.43.1 Wake Forest Baptist Medical Center Pipeline Products and Ongoing Clinical Trials Overview 330
5.44 Washington University in St. Louis Company Overview 331
5.44.1 Washington University in St. Louis Pipeline Products and Ongoing Clinical Trials Overview 331
5.45 Xend Company Overview 332
5.45.1 Xend Pipeline Products and Ongoing Clinical Trials Overview 332
5.46 Z Lens LLC Company Overview 333
5.46.1 Z Lens LLC Pipeline Products and Ongoing Clinical Trials Overview 333
5.47 Ziemer Ophthalmic Systems AG Company Overview 334
5.47.1 Ziemer Ophthalmic Systems AG Pipeline Products and Ongoing Clinical Trials Overview 334
6 Cataract Surgery Devices- Recent Developments 338
7 Appendix 378
7.1 Methodology 378
7.2 About GlobalData 380
7.3 Contact Us 381
7.4 Disclaimer 381

1.1 List of Tables
Table 1: Cataract Surgery Devices - Pipeline Products by Stage of Development 21
Table 2: Cataract Surgery Devices - Pipeline Products by Segment 22
Table 3: Cataract Surgery Devices - Pipeline Products by Territory 23
Table 4: Cataract Surgery Devices - Pipeline Products by Regulatory Path 24
Table 5: Cataract Surgery Devices - Pipeline Products by Estimated Approval Date 25
Table 6: Cataract Surgery Devices - Ongoing Clinical Trials 26
Table 7: Cataract Surgery Devices Companies - Pipeline Products by Stage of Development 27
Table 8: Cataract Surgery Devices - Pipeline Products by Stage of Development 29
Table 9: Abbott Medical Optics, Inc. Pipeline Products and Ongoing Clinical Trials Overview 37
Table 10: Enhanced Phacoemulsification System - Product Status 38
Table 11: Enhanced Phacoemulsification System - Product Description 38
Table 12: Intraocular Lens - Astigmatism - Product Status 39
Table 13: Intraocular Lens - Astigmatism - Product Description 39
Table 14: Intraocular Lens - Presbyopia - Product Status 40
Table 15: Intraocular Lens - Presbyopia - Product Description 40
Table 16: Modified Light Transmission IOL - Product Status 41
Table 17: Modified Light Transmission IOL - Product Description 41
Table 18: Synchrony Dual Optic Accommodating IOL - Enhanced Version - Product Status 42
Table 19: Synchrony Dual Optic Accommodating IOL - Enhanced Version - Product Description 42
Table 20: TECNIS-1 Monofocal IOL - Product Status 43
Table 21: TECNIS-1 Monofocal IOL - Product Description 43
Table 22: Unfolder Platinum 1 - Product Status 44
Table 23: Unfolder Platinum 1 - Product Description 44
Table 24: Adoptics AG Pipeline Products and Ongoing Clinical Trials Overview 45
Table 25: Shape-Changing Accommodating Intraocular Lens - Product Status 45
Table 26: Shape-Changing Accommodating Intraocular Lens - Product Description 45
Table 27: Advanced Refractive Technologies, Inc. Pipeline Products and Ongoing Clinical Trials Overview 46
Table 28: Accupulse Cataract Emulsifier - Product Status 47
Table 29: Accupulse Cataract Emulsifier - Product Description 47
Table 30: Lens Opacity Threshold System - Product Status 48
Table 31: Lens Opacity Threshold System - Product Description 48
Table 32: AkkoLens International BV Pipeline Products and Ongoing Clinical Trials Overview 49
Table 33: AkkoLens AIOL - Product Status 49
Table 34: AkkoLens AIOL - Product Description 49
Table 35: Alcon, Inc. Pipeline Products and Ongoing Clinical Trials Overview 50
Table 36: Accommodative Intraocular Lens - Product Status 51
Table 37: Accommodative Intraocular Lens - Product Description 51
Table 38: Acrysof IQ Restor +8 Multifocal Intraocular Lens - Product Status 52
Table 39: Acrysof IQ Restor +8 Multifocal Intraocular Lens - Product Description 52
Table 40: AcrySof IQ ReSTOR 3.0D Toric IOL - Product Status 53
Table 41: AcrySof IQ ReSTOR 3.0D Toric IOL - Product Description 53
Table 42: AcrySof IQ ReSTOR 3.0D Toric IOL Diopter Range Expansion - Product Status 54
Table 43: AcrySof IQ ReSTOR 3.0D Toric IOL Diopter Range Expansion - Product Description 54
Table 44: AcrySof IQ ReSTOR Distant Dominant 2.5D - Product Status 55
Table 45: AcrySof IQ ReSTOR Distant Dominant 2.5D - Product Description 55
Table 46: AcrySof IQ ReSTOR Multifocal Toric Lens - Product Status 56
Table 47: AcrySof IQ ReSTOR Multifocal Toric Lens - Product Description 56
Table 48: AcrySof IQ ReSTOR Toric IOL 2.5D - Product Status 57
Table 49: AcrySof IQ ReSTOR Toric IOL 2.5D - Product Description 57
Table 50: AcrySof IQ ReSTOR Toric IOL Diopter Range Expansion - Product Status 58
Table 51: AcrySof IQ ReSTOR Toric IOL Diopter Range Expansion - Product Description 58
Table 52: AcrySof IQ Toric Diopter Range Expansion - Product Status 59
Table 53: AcrySof IQ Toric Diopter Range Expansion - Product Description 59
Table 54: AcrySof IQ Toric IOL Low Diopter Range Expansion - Product Status 60
Table 55: AcrySof IQ Toric IOL Low Diopter Range Expansion - Product Description 60
Table 56: Intrepid IOL - Product Status 61
Table 57: Intrepid IOL - Product Description 61
Table 58: LenSx Laser System Expansion - Product Status 62
Table 59: LenSx Laser System Expansion - Product Description 62
Table 60: Alcon, Inc. - Ongoing Clinical Trials Overview 63
Table 61: AcrySof IQ ReSTOR Multifocal Toric Lens - Evaluation of the Visual Acuity After the Implantation of a ReSTOR +2.5 Diopters Intraocular Lens (ReSTOR SV25T0) in the Distance Dominant Eye, in Combination With a +3.0 Diopters ReSTOR Intraocular Lens (ReSTOR SN6AD1) in the Fellow Eye 64
Table 62: Altacor Limited Pipeline Products and Ongoing Clinical Trials Overview 65
Table 63: SOLO - Product Status 65
Table 64: SOLO - Product Description 65
Table 65: Anew Optics, Inc. Pipeline Products and Ongoing Clinical Trials Overview 66
Table 66: Zephyr Lens - Product Status 66
Table 67: Zephyr Lens - Product Description 66
Table 68: Bausch and Lomb Incorporated Pipeline Products and Ongoing Clinical Trials Overview 67
Table 69: Cirle 3-D Surgical Navigation System - Product Status 68
Table 70: Cirle 3-D Surgical Navigation System - Product Description 68
Table 71: Sarfarazi Elliptical Accommodating IOL - Product Status 69
Table 72: Sarfarazi Elliptical Accommodating IOL - Product Description 69
Table 73: Calhoun Vision, Inc. Pipeline Products and Ongoing Clinical Trials Overview 70
Table 74: Light Adjustable Lens - Product Status 71
Table 75: Light Adjustable Lens - Product Description 71
Table 76: Elenza, Inc. Pipeline Products and Ongoing Clinical Trials Overview 72
Table 77: Sapphire Autofocal IOL - Product Status 72
Table 78: Sapphire Autofocal IOL - Product Description 72
Table 79: Eye Care and Cure Pipeline Products and Ongoing Clinical Trials Overview 73
Table 80: Ophthalmic Device - Cataract Surgery - Product Status 73
Table 81: Ophthalmic Device - Cataract Surgery - Product Description 73
Table 82: EyeKon Medical, Inc. Pipeline Products and Ongoing Clinical Trials Overview 74
Table 83: AcuGel Plus Viscoelastics - Product Status 78
Table 84: AcuGel Plus Viscoelastics - Product Description 78
Table 85: AcuGel SH Viscoelastics - Product Status 79
Table 86: AcuGel SH Viscoelastics - Product Description 79
Table 87: AcuGel Viscoelastics - Product Status 80
Table 88: AcuGel Viscoelastics - Product Description 80
Table 89: Acuity 1 Disposable Injector - Product Status 81
Table 90: Acuity 1 Disposable Injector - Product Description 81
Table 91: Acuity Capsular Tension Ring 10mm - Product Status 82
Table 92: Acuity Capsular Tension Ring 10mm - Product Description 82
Table 93: Acuity Capsular Tension Ring 12mm - Product Status 83
Table 94: Acuity Capsular Tension Ring 12mm - Product Description 83
Table 95: ACUITY FA55A-4NY IOL - Product Status 84
Table 96: ACUITY FA55A-4NY IOL - Product Description 84
Table 97: Acuity FA55A-4UV IOL - Product Status 85
Table 98: Acuity FA55A-4UV IOL - Product Description 85
Table 99: Acuity FB25B - UV IOL - Product Status 86
Table 100: Acuity FB25B - UV IOL - Product Description 86
Table 101: Acuity FB25B-NY IOL - Product Status 87
Table 102: Acuity FB25B-NY IOL - Product Description 87
Table 103: Acuity FS25B-NY IOL - Product Status 88
Table 104: Acuity FS25B-NY IOL - Product Description 88
Table 105: Acuity FS25B-UV IOL - Product Status 89
Table 106: Acuity FS25B-UV IOL - Product Description 89
Table 107: Acuity FS60S - 4NY IOL - Product Status 90
Table 108: Acuity FS60S - 4NY IOL - Product Description 90
Table 109: Acuity FS60S - 4UV IOL - Product Status 91
Table 110: Acuity FS60S - 4UV IOL - Product Description 91
Table 111: Acuity SB25B IOL - Product Status 92
Table 112: Acuity SB25B IOL - Product Description 92
Table 113: Acuity SB25B-NY IOL - Product Status 93
Table 114: Acuity SB25B-NY IOL - Product Description 93
Table 115: Acuity TN60 - 2NY IOL - Product Status 94
Table 116: Acuity TN60 - 2NY IOL - Product Description 94
Table 117: Acuity TN60-OUV IOL - Product Status 95
Table 118: Acuity TN60-OUV IOL - Product Description 95
Table 119: Acuity UB60-0UV IOL - Product Status 96
Table 120: Acuity UB60-0UV IOL - Product Description 96
Table 121: Acuity UY60 - OUV IOL - Product Status 97
Table 122: Acuity UY60 - OUV IOL - Product Description 97
Table 123: Acurus AA55A-41 IOL - Product Status 98
Table 124: Acurus AA55A-41 IOL - Product Description 98
Table 125: Acurus AA55A-44 IOL - Product Status 99

1.2 List of Figures
Figure 1: Cataract Surgery Devices - Pipeline Products by Stage of Development 21
Figure 2: Cataract Surgery Devices - Pipeline Products by Segment 22
Figure 3: Cataract Surgery Devices - Pipeline Products by Territory 23
Figure 4: Cataract Surgery Devices - Pipeline Products by Regulatory Path 24
Figure 5: Cataract Surgery Devices - Pipeline Products by Estimated Approval Date 25
Figure 6: Cataract Surgery Devices - Ongoing Clinical Trials 26

Companies mentioned
Abbott Medical Optics, Inc.
Adoptics AG
Advanced Refractive Technologies, Inc.
AkkoLens International BV
Alcon, Inc.
Altacor Limited
Anew Optics, Inc.
Bausch and Lomb Incorporated
Calhoun Vision, Inc.
Elenza, Inc.
Eye Care and Cure
EyeKon Medical, Inc.
Glaukos Corporation
Hoya Surgical Optics, Inc.
HumanOptics AG
Imperial Medical Technologies, Inc
InnFocus LLC
Innovia LLC
International Biomedical
LensGen, Inc.
London Eye Hospital Pharma
Massachusetts Institute of Technology
Meir Medical Center
Morcher Gmbh
Mynosys Cellular Devices, Inc.
NuLens Ltd.
Oculentis GmbH
OptMed, Inc.
OptoLight Vision Technology
Paradigm Medical Industries, Inc.
PowerVision, Inc.
Presbeasy
Rayner Intraocular Lenses Limited
Rhexis Biomedical
Sharklet Technologies, Inc.
STAAR Surgical Company
Tear Diagno LLC
TEKIA, Inc.
University of Florida
University of Rochester
University of Texas Medical Branch at Galveston
Visioneering Technologies, Inc.
Wake Forest Baptist Medical Center
Washington University in St. Louis
Xend
Z Lens LLC
Ziemer Ophthalmic Systems AG

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Frontier Pharma: Ophthalmology Therapeutics - Advancements in Disease Understanding Pave Way for Increasingly Diverse Therapeutic Options, with Age-Related Macular Degeneration and Glaucoma Leading the Way

Frontier Pharma: Ophthalmology Therapeutics - Advancements in Disease Understanding Pave Way for Increasingly Diverse Therapeutic Options, with Age-Related Macular Degeneration and Glaucoma Leading the Way

  • $ 6995
  • Industry report
  • September 2016
  • by GBI Research

Frontier Pharma: Ophthalmology Therapeutics - Advancements in Disease Understanding Pave Way for Increasingly Diverse Therapeutic Options, with Age-Related Macular Degeneration and Glaucoma Leading the ...

Canada Ophthalmic Devices Market Outlook to 2022 - Cataract Surgery Devices, Intraocular Lens (IOL), Vitreo Retinal Surgery Devices, Glaucoma Surgery Devices, Ophthalmic Lasers, Ophthalmic Diagnostic Equipment and Vision Care

Canada Ophthalmic Devices Market Outlook to 2022 - Cataract Surgery Devices, Intraocular Lens (IOL), Vitreo Retinal Surgery Devices, Glaucoma Surgery Devices, Ophthalmic Lasers, Ophthalmic Diagnostic Equipment and Vision Care

  • $ 5995
  • Industry report
  • December 2016
  • by Global Data

Canada Ophthalmic Devices Market Outlook to 2022 - Cataract Surgery Devices, Intraocular Lens (IOL), Vitreo Retinal Surgery Devices, Glaucoma Surgery Devices, Ophthalmic Lasers, Ophthalmic Diagnostic Equipment ...

United Kingdom Ophthalmic Devices Market Outlook to 2022 - Cataract Surgery Devices, Intraocular Lens (IOL), Vitreo Retinal Surgery Devices, Glaucoma Surgery Devices, Ophthalmic Lasers, Ophthalmic Diagnostic Equipment and Vision Care

United Kingdom Ophthalmic Devices Market Outlook to 2022 - Cataract Surgery Devices, Intraocular Lens (IOL), Vitreo Retinal Surgery Devices, Glaucoma Surgery Devices, Ophthalmic Lasers, Ophthalmic Diagnostic Equipment and Vision Care

  • $ 5995
  • Industry report
  • December 2016
  • by Global Data

United Kingdom Ophthalmic Devices Market Outlook to 2022 - Cataract Surgery Devices, Intraocular Lens (IOL), Vitreo Retinal Surgery Devices, Glaucoma Surgery Devices, Ophthalmic Lasers, Ophthalmic Diagnostic ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.